Real-world monitoring of circulating tumor DNA reliably predicts cancer recurrence in patients with resected stages I-III colorectal cancer

被引：2

作者：

Cohen, S. A. ^{[1
,2
]}

Kasi, P. M. ^{[3
]}

Aushev, V. N. ^{[4
]}

Hanna, D. L. ^{[5
]}

Botta, G. P. ^{[6
]}

Sharif, S. ^{[7
]}

Laliotis, G. ^{[4
]}

Sharma, S. ^{[4
]}

Sharma, V. ^{[8
]}

Alqahtani, A. ^{[9
]}

Chandana, S. R. ^{[10
]}

Kang, S. ^{[11
]}

Chakrabarti, S. ^{[12
]}

Somer, B. G. ^{[13
]}

Kasi, A. ^{[14
]}

Dayyani, F. ^{[15
]}

Malla, M. ^{[16
]}

Jurdi, A. ^{[4
]}

Aleshin, A. ^{[4
]}

Kopetz, S. ^{[17
]}

机构：

[1] Univ Washington, Med Oncol, Seattle, WA USA

[2] Fred Hutchinson Canc Ctr, Seattle, WA USA

[3] New York Presbyterian Hosp, Englander Inst Precis Med, Oncol Hematol Dept, Weill Cornell Med, New York, NY USA

[4] Natera Inc, Oncol, Austin, TX USA

[5] USC Univ Southern Calif, Med Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[6] UCSD Moores Canc Ctr, Div Hematol Oncol, Med, La Jolla, CA USA

[7] Univ Iowa, Med Oncol, Holden Comprehens Canc Ctr, Iowa City, IA USA

[8] James Graham Brown Canc Ctr, Med Oncol, Louisville, KY USA

[9] Georgetown Univ, Ruesch Ctr Cure Gastrointestinal Canc, Lombardi Comprehens Canc Ctr, Med Oncol,Med Ctr, Washington, DC USA

[10] Canc & Hematol Ctr Western Michigan, Oncol Hematol Dept, Grand Rapids, MI USA

[11] Emory Univ, Oncol Hematol Dept, Winship Canc Inst, Atlanta, GA USA

[12] Med Coll Wisconsin, Med Oncol, Milwaukee, WI USA

[13] West Canc Ctr, Med Oncol, Germantown, TN USA

[14] KUMC Univ Kansas Med Ctr, Med Oncol, Kansas City, KS USA

[15] Univ Calif Irvine, Med Dept, Chao Family Comprehens Canc Ctr, Orange, CA USA

[16] West Virginia Univ, Hematol Oncol, Inst Canc, Morgantown, WV USA

[17] Univ Texas MD Anderson Canc Ctr, GI Med Oncol Dept, Houston, TX USA

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.457

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

319MO

引用

下载

页码：S683 / S684

页数：2

共 50 条

[1] Circulating tumor DNA analysis predicting recurrence risk in patients with stage I-III colorectal cancer
Gu, J.
Lei, F.
Wang, X.
Huang, W.
He, X.
Hong, Y.
Zeng, Q.
Wang, Y.
Gao, Q.
Niu, P.
Huang, D.
Gao, Z.
Ding, C.
Zhai, Z.
An, K.
Chen, H.
Zhao, X.
Chen, S.
Bai, Y.
ANNALS OF ONCOLOGY, 2021, 32 : S561 - S561
[2] Circulating tumor cells in patients with breast cancer I-III stages
Ponomarev, V.
Chernysheva, O.
Polikarpova, S.
Kirsanov, V.
Bogush, E.
Tupitsyn, N.
LEUKEMIA RESEARCH, 2019, 85 : S71 - S71
[3] The prognostic value of circulating in blood tumor DNA after surgery in I-III stages colorectal cancer
Polyanskaya, E.
Fedyanin, M.
Uliana, B.
Kechin, A.
Moroz, E.
Khrapov, E.
Oskorobin, I.
Darya, S.
Aliev, V.
Tryakin, A.
Filipenko, M.
Tjulandin, S.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S712 - S713
[4] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of patients with stages I-III colorectal cancer
Zhou, Jian
Yang, Jian
Zhang, Zixiang
Li, Ye
Yi, Bin
Tang, Yuchen
Li, Dechun
Li, Xiaozhe
Peng, Di
Li, Xi
Wang, Yang
Li, Haiyan
Li, Bing
Wang, Chenyang
Zhu, Pengfei
Chen, Longfei
Wu, Shuailai
Fang, Shuai
Li, Chenxi
Qiu, Fujun
Chuai, Shannon
Zhang, Zhihong
CANCER RESEARCH, 2022, 82 (12)
[5] Monitoring circulating tumor DNA predicts cancer recurrence by using liquid biopsy in a colorectal cancer patient
Hung, Chia Cheng
Huang, Hwei Ming
Lin, Tze Kang
Huang, Chieh Wei
Yeh, Chang Wei
Su, Yi Ning
EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 462 - 462
[6] Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
Gong Chen
Junjie Peng
Qian Xiao
Hao-Xiang Wu
Xiaojun Wu
Fulong Wang
Liren Li
Peirong Ding
Qi Zhao
Yaqi Li
Da Wang
Yang Shao
Hua Bao
Zhizhong Pan
Ke-Feng Ding
Sanjun Cai
Feng Wang
Rui-Hua Xu
Journal of Hematology & Oncology, 14
[7] Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
Chen, Gong
Peng, Junjie
Xiao, Qian
Wu, Hao-Xiang
Wu, Xiaojun
Wang, Fulong
Li, Liren
Ding, Peirong
Zhao, Qi
Li, Yaqi
Wang, Da
Shao, Yang
Bao, Hua
Pan, Zhizhong
Ding, Ke-Feng
Cai, Sanjun
Wang, Feng
Xu, Rui-Hua
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[8] Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
Zhaoya Gao
Dandan Huang
Hui Chen
Yong Yang
Ke An
Changmin Ding
Zheping Yuan
Zhichao Zhai
Pengfei Niu
Qingkun Gao
Jinping Cai
Qingmin Zeng
Yanzhao Wang
Yuming Hong
Wanshui Rong
Wensheng Huang
Fuming Lei
Xiaodong Wang
Shiqing Chen
Xiaochen Zhao
Yuezong Bai
Jin Gu
Journal of Translational Medicine, 21
[9] Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
Gao, Zhaoya
Huang, Dandan
Chen, Hui
Yang, Yong
An, Ke
Ding, Changmin
Yuan, Zheping
Zhai, Zhichao
Niu, Pengfei
Gao, Qingkun
Cai, Jinping
Zeng, Qingmin
Wang, Yanzhao
Hong, Yuming
Rong, Wanshui
Huang, Wensheng
Lei, Fuming
Wang, Xiaodong
Chen, Shiqing
Zhao, Xiaochen
Bai, Yuezong
Gu, Jin
JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
[10] Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer
Brown, Justin C.
Rhim, Andrew D.
Manning, Sara L.
Brennan, Luke
Mansour, Alexandra I.
Rustgi, Anil K.
Damjanov, Nevena
Troxel, Andrea B.
Rickels, Michael R.
Ky, Bonnie
Zemel, Babette S.
Courneya, Kerry S.
Schmitz, Kathryn H.
PLOS ONE, 2018, 13 (10):

← 1 2 3 4 5 →